Search Results 3251-3260 of 25402 for oral

  1. Short Bowel Syndrome and Teduglutide VS Placebo - Mayo Clinic

    Diuretics and oral rehydration solutions will be required to be stable for ≥4 weeks prior to baseline evaluations and remain stable during the study.

  2. Liothyronine (intravenous route) - Mayo Clinic

    Hypothyroidism is a condition where the thyroid gland does not produce enough thyroid hormone . Liothyronine injection can be used as a substitute for the oral ...

  3. Mayo Clinic Minute Treating male hair loss VIDEO AUDIO Have you heard you can predict what will happen to your hair by looking a

    Oral medicine. Finasteride. A topical medication called minoxidil and an oral medicine called finasteride regrows or maintains hair in some men. Leila ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  5. A Study to Evaluate Lamprene (Clofazimine) to Treat Non-Tuberculous Mycobacterial (NTM) Infections - Mayo Clinic

    ... oral or injected or implanted hormonal contraception or intra-uterine device or with spermicidal foam/gel/film/ cream/vaginal suppository;; Use of oral ...

  6. Mayo Clinic Q and A: Increasing incidence of throat cancer related to HPV

    Two strains of HPV cause 70% of all cervical cancer. HPV infections also can lead to other genital and anal cancers in females, as well as penile and anal ...

  7. Management of recurrent Clostridioides difficile infection and use of fecal microbiota transplantation during the COVID-19 pandemic - Mayo Clinic

    Primary and first recurrence CDIs are typically treated with oral vancomycin or fidaxomicin regimens. Although it has not yet been approved by the Food and Drug ...

  8. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

    difficile infection (CDI) after a primary episode and have completed at least two rounds of standard-of-care oral antibiotic therapy or have had at least ...

  9. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

    Background regimen for UC may include oral 5-aminosalicylic acid (5-ASA), oral corticosteroids, budesonide multi-matrix system (MMX), probiotics ...

  10. MBI Response toTam - Clinical Trials

    Hormonal contraception (oral, transdermal, implanted, or injected formulations) Hormonal IUDs are allowed; Selective estrogen receptor modulators (tamoxifen ...